Azithromycin for the secondary prevention of coronary heart disease events. The WIZARD study: a randomized controlled trial

O'Connor, C.M.; Dunne, M. W.; Pfeffer, Michael

doi:10.1016/j.accreview.2003.10.066

Cited by 119 publications

(155 citation statements)

References 0 publications

Supporting

Mentioning

145

Contrasting

Unclassified

Order By: Relevance

“…Trial populations were slightly variable. Six trials were conducted among patients with stable coronary artery disease (10,(13)(14)(15)(16)(17) and six trials involved patients with acute coronary syndromes (18)(19)(20)(21)(22)(23). The remaining trial was conducted among patients scheduled to undergo coronary artery bypass graft surgery (24).…”

Section: Resultsmentioning

confidence: 99%

“…The remaining trial was conducted among patients scheduled to undergo coronary artery bypass graft surgery (24). Three trials (10,13,14) included anti-Chlamydia immunoglobulin (Ig)G titres as part of their inclusion criteria. Trials examined the use of one of four different antibiotics: azithromycin (seven trials) (10,(13)(14)(15)(19)(20)(21), roxithromycin (two trials) (17,22), clarithromycin (three trials) (16,23,24) and gatifloxacin (one trial) (18).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases

Song

Brassard

Brophy

2008

Canadian Journal of Cardiology

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases

Song

Brassard

Brophy

2008

Canadian Journal of Cardiology

View full text Add to dashboard Cite

“…WIZARD (Weekly Intervention with Zithromax for Atherosclerosis and Related Disorder) study 24 failed to find a long term benefit of administering Azithromycin for individuals with stable coronary artery disease, serologic evidence of C. Pneumoniae and past history of myocardial infarction. The ineffectiveness of antibiotics for prevention of secondary cardiovascular events has also been shown in ACES, 25 PROVE IT-TIMI 26 and AZACS 27 trials.…”

Section: Discussionmentioning

confidence: 99%

Early prognosis of unstable angina patients with positive Helicobacter pylori IgG values

Kaulgud

Kamath

2013

Int Jour of Biomed Res

View full text Add to dashboard Cite

“…Ис-следование The Northern Manhattan Stroke Study [58,59] показало, что повышенные титры IgA к Chlamydia pneumoniae тесно ассоциируются с высоким риском развития инсульта. Тем не менее попытки примене-ния антибиотиков для профилактики инсульта успешными не были [60].…”

Section: системные и церебральные васкулитыunclassified

New risk factors of stroke in young adults

Yevtushenko

Filimonov

Yevtushenko

2015

Z. nevrol. psikhiatr. im. S.S. Korsakova

View full text Add to dashboard Cite

Gorky Donetsk national medical universityСогласно современным представлениям, до 75% случаев развития инсульта в общей популяции можно связать с действием общепринятых (базисных) факторов риска, таких как артериальная гипертензия, атеросклероз, нарушения ритма сердца, сахарный диабет. тем не менее до 25% случаев инсульта связано с воздействием иных факторов риска, особенно у лиц молодого возраста. в настоящем обзоре даны анализ и оценка наиболее значимых новых факторов риска развития инсульта у лиц молодого возраста, таких как генетическая предрасположенность, болезнь малых сосудов, гипергомоцистеинемия, тромбофилии, наличие «немых» инфарктов мозга и др. Акцентировано внимание на роли новых факторов риска развития инсульта у женщин. на основании современных данных литературы и личных наблюдений приводятся модифицированные критерии клинической оценки новых факторов риска. обоснован паттерн лабораторных исследований, направленных на оценку риска развития инсульта. ключевые слова: инсульт, новые факторы риска, молодой возраст.According to the modern point of view, up to 75% stroke cases may be associated with conventional (basic) risk factors such as hypertension, atherosclerosis, cardiac arrhythmia, diabetes, and others. however, up to 25% of stroke cases are associated with the influence of other risk factors, especially among young people. in this review, an analysis and evaluation of the most significant new stroke risk factors in young adults, such as genetic predisposition, «small» vessels disease, hyperhomocysteinemia, thrombophilia, «silent» brain infarction and others was made. Attention was paid to a role of new stroke risk factors in women. in this review, criteria for clinical evaluation of new stroke risk factors and pattern of laboratory tests to determine the stroke risk were defined based on current literature and personal observations. keywords: stroke, new risk factors, young age.

show abstract

Azithromycin for the secondary prevention of coronary heart disease events. The WIZARD study: a randomized controlled trial

Cited by 119 publications

References 0 publications

A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases

A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases

Early prognosis of unstable angina patients with positive Helicobacter pylori IgG values

New risk factors of stroke in young adults

Contact Info

Product

Resources

About